SESEN BIO INC (SESN) Stock Price, Quote, News and Overview
NASDAQ:SESN - Nasdaq - US8177631053 - Common Stock - Currency: USD
SESN Quote, Performance and Key Statistics
0.6288
+0.04 (+7.29%)
The current stock price of SESN is 0.6288 USD. In the past month the price increased by 8.32%. In the past year, price increased by 0.5%.
SESN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About SESN
Company Profile
Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. The company is headquartered in Cambridge, Massachusetts and currently employs 35 full-time employees. The company went IPO on 2014-02-06. The firm's product candidates are based on its TFPT platform and are focused on addressing areas of unmet medical need in cancer. TFPTs are single protein therapeutics composed of targeting domains genetically fused via peptide linkers to cytotoxic protein payloads that are produced through its recombinant one-step, microbial manufacturing process. The Company’s advanced product candidate Vicinium, also known as VB4-845, which is composed of an anti-epithelial cell adhesion molecule (EpCAM) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of bacillus calmette-guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC).
Company Info
SESEN BIO INC
245 1st St Ste 1800
Cambridge MASSACHUSETTS 02142 US
CEO: Thomas R. Cannell
Employees: 35
Company Website: https://sesenbio.com/
Phone: 16174448550.0
SESEN BIO INC / SESN FAQ
What is the stock price of SESEN BIO INC today?
The current stock price of SESN is 0.6288 USD. The price increased by 7.29% in the last trading session.
What is the ticker symbol for SESEN BIO INC stock?
The exchange symbol of SESEN BIO INC is SESN and it is listed on the Nasdaq exchange.
On which exchange is SESN stock listed?
SESN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SESEN BIO INC stock?
6 analysts have analysed SESN and the average price target is 12.24 USD. This implies a price increase of 1846.56% is expected in the next year compared to the current price of 0.6288. Check the SESEN BIO INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SESEN BIO INC worth?
SESEN BIO INC (SESN) has a market capitalization of 127.96M USD. This makes SESN a Micro Cap stock.
How many employees does SESEN BIO INC have?
SESEN BIO INC (SESN) currently has 35 employees.
What are the support and resistance levels for SESEN BIO INC (SESN) stock?
SESEN BIO INC (SESN) has a support level at 0.63 and a resistance level at 0.64. Check the full technical report for a detailed analysis of SESN support and resistance levels.
Is SESEN BIO INC (SESN) expected to grow?
The Revenue of SESEN BIO INC (SESN) is expected to decline by -100% in the next year. Check the estimates tab for more information on the SESN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SESEN BIO INC (SESN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SESN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SESN, evaluating the profitability, health, valuation and growth aspects
- SESEN BIO INC (SESN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SESEN BIO INC (SESN) Sales and EPS estimates to see what analysts future expectations are.
- SESEN BIO INC (SESN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SESEN BIO INC (SESN) Insider and Institutional Ownership to learn about the owners and their transactions.
- SESEN BIO INC (SESN) Stock Chart to make your own analysis
- SESEN BIO INC (SESN) Latest news and press-releases to stay up to date.
Does SESEN BIO INC (SESN) stock pay dividends?
SESN does not pay a dividend.
When does SESEN BIO INC (SESN) report earnings?
SESEN BIO INC (SESN) will report earnings on 2023-05-08.
What is the Price/Earnings (PE) ratio of SESEN BIO INC (SESN)?
SESEN BIO INC (SESN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.16).
SESN Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to SESN. When comparing the yearly performance of all stocks, SESN is one of the better performing stocks in the market, outperforming 90% of all stocks.
SESN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SESN. SESN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
SESN Financial Highlights
Over the last trailing twelve months SESN reported a non-GAAP Earnings per Share(EPS) of -1.16. The EPS decreased by -364% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
SESN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to SESN. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of -308% and a revenue growth -100% for SESN